Drug-Masking Technology Lands Biotech Company Possible $500 Million Deal
The deal between CytomX Therapeutics Inc. and AbbVie Inc. is aimed at a tough-to-target protein found in many cancers.
The San Francisco Business Journal:
Masked Cancer-Fighter Lands Peninsula Biotech Company A Potential $500 Million Drug Deal
This drug-masking technology landed a Peninsula biotech company a potential $500 million deal to fight cancer. (Leuty, 4/21)